Asian Growth Companies With High Insider Ownership September 2026
In September 2026, the Asian markets are navigating a complex landscape marked by geopolitical tensions and fluctuating oil prices, which have influenced investor sentiment and market dynamics. Amidst this backdrop, growth companies with high insider ownership can offer unique insights into potential resilience and alignment of interests between management and shareholders.
Top 10 Growth Companies With High Insider Ownership In Asia
| Name | Insider Ownership | Earnings Growth |
| Zhejiang Taotao Vehicles (SZSE:301345) | 27.9% | 31.7% |
| Suzhou Dongshan Precision Manufacturing (SZSE:002384) | 33.5% | 75.5% |
| SEERS (KOSDAQ:A458870) | 33.8% | 35.7% |
| Ningbo Sanxing Medical ElectricLtd (SHSE:601567) | 24.9% | 56.8% |
| Meiko Electronics (TSE:6787) | 19.2% | 33.8% |
| HUMAN MADE (TSE:456A) | 23.9% | 28.8% |
| Great Microwave Technology (SHSE:688270) | 21.1% | 95.2% |
| Gpixel Changchun Microelectronics (SEHK:3277) | 18.2% | 31.9% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 14.1% | 39.2% |
| Beijing Luzhu Biotechnology (SEHK:2480) | 39.7% | 84.3% |
We'll examine a selection from our screener results.
Chery Automobile (SEHK:9973)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Chery Automobile Co., Ltd. is engaged in the design, development, manufacture, and sale of passenger vehicles and automotive parts both in China and internationally, with a market cap of approximately HK$149.40 billion.
Operations: The company's revenue primarily comes from its Auto Manufacturers segment, which generated CN¥301.97 billion.
Insider Ownership: 15.9%
Chery Automobile demonstrates characteristics of a growth company with high insider ownership, evidenced by substantial insider buying over the past three months. The company's revenue and earnings are forecast to grow faster than the Hong Kong market, with analysts expecting a significant stock price increase. Chery's strategic initiatives include launching new models like FREELANDER 8 in China and expanding its NEV brand LEPAS globally. Despite trading below fair value estimates, challenges remain in sustaining dividend coverage through free cash flows.
- Click to explore a detailed breakdown of our findings in Chery Automobile's earnings growth report.
- The analysis detailed in our Chery Automobile valuation report hints at an deflated share price compared to its estimated value.
3Peak (SHSE:688536)
Simply Wall St Growth Rating: ★★★★★☆
Overview: 3Peak Incorporated focuses on the research, development, testing, and sale of integrated circuits, application systems, and software both in China and internationally with a market cap of CN¥43.24 billion.
Operations: The company's revenue is primarily derived from the integrated circuit industry, amounting to CN¥2.80 billion.
Insider Ownership: 13.4%
3Peak exhibits strong growth potential with high insider ownership, as evidenced by its impressive financial performance. The company's earnings and revenue are forecast to grow significantly faster than the Chinese market, with expected annual profit growth of 39.5% and revenue growth of 28.2%. Recently, 3Peak reported a substantial increase in sales to CNY 1.61 billion for H1 2026, up from CNY 948.9 million a year ago, highlighting its robust expansion trajectory despite share price volatility.
- Take a closer look at 3Peak's potential here in our earnings growth report.
- The valuation report we've compiled suggests that 3Peak's current price could be inflated.
AcrobiosystemsLtd (SZSE:301080)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Acrobiosystems Co., Ltd. develops and manufactures recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies as well as research institutions, with a market cap of CN¥15.34 billion.
Operations: Acrobiosystems Co., Ltd. generates revenue through the creation and production of recombinant proteins, antibodies, and biological reagents catering to pharmaceutical firms, biotech companies, and research institutions.
Insider Ownership: 35.2%
Acrobiosystems Ltd. demonstrates growth potential with high insider ownership, reporting H1 2026 sales of CNY 499.59 million and net income of CNY 98.36 million, reflecting year-over-year increases. Earnings are forecast to grow at a significant rate of 29.5% annually, outpacing the Chinese market's average growth. Recent strategic moves include a share buyback program and increased registered capital, although its share price remains highly volatile and expected return on equity is projected to be modest at 11.7%.
- Delve into the full analysis future growth report here for a deeper understanding of AcrobiosystemsLtd.
- Insights from our recent valuation report point to the potential overvaluation of AcrobiosystemsLtd shares in the market.
Seize The Opportunity
- Discover the full array of 497 Fast Growing Asian Companies With High Insider Ownership right here.
- Searching for a Fresh Perspective? Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com